Fig. 3From: Oligomeric forms of amyloid-β protein in plasma as a potential blood-based biomarker for Alzheimer’s diseaseCorrelations between plasma Aβ oligomer levels determined using the Multimer Detection System, and other amyloid biomarkers of Alzheimer’s disease. a There was a negative correlation between CSF Aβ42 levels and the PIB SUVR. b Plasma Aβ oligomer levels were moderately negatively correlated with CSF Aβ42 levels. c There was a positive correlation between plasma Aβ oligomer levels and PIB SUVR. d CSF pTau and e tTau levels also correlated positively with plasma Aβ oligomer levels. MDS RLU Multimer Detection System relative luminescence units, CSF Aβ 42 Cerebrospinal fluid amyloid-β 1–42 peptide, PIB SUVR 11C-Pittsburgh compound B standardized uptake value ratio, pTau Phosphorylated tau protein, tTau Total tau protein, AD Patients with Alzheimer’s disease, NC Cognitively normal control subjectsBack to article page